Asean

SELLAS Life Sciences Announces Positive Pivotal Phase 3 REGAL Trial Data Showing Immunotherapeutic Cancer Vaccine, Galinpepimut-S (GPS), Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with Acute Myeloid Leukemia

– REGAL trial met its primary endpoint with GPS demonstrating statistically significant and clinically meaningful reduction in risk of death by 41% with median overall survival of 24.0 months versus 14.7 months for best available treatment, and a hazard ratio of 0.59 (p=0.035) – – Company plans to meet with the U.S. Food and Drug […]

Read More

EAACI calls for allergy and respiratory health to be part of climate action at COP31

A dedicated symposium will connect scientific evidence, patient needs and climate policy, advancing EAACI’s vision of a future free from the burden of allergy and asthma. ZURICH, Switzerland, Nov. 16, 2026 (GLOBE NEWSWIRE) — The European Academy of Allergy and Clinical Immunology (EAACI) will bring allergy and respiratory health into the dialogue at COP31, advocating […]

Read More

YYForce Sets Operating Priorities Across AI Workforce, Robotics and Facility Management

Company Targets Commercial Robotics Scaling, Humanoid R&D and Disciplined Cash Generation SINGAPORE, Nov. 16, 2026 (GLOBE NEWSWIRE) — YYForce Inc. (NASDAQ: YFOR) (“YYForce” or the “Company”), an AI-enabled frontline workforce, robotics, and facility solutions provider, today outlined its operating priorities across frontline staffing, integrated facility management and commercial robotics. YYForce is focused on improving staffing […]

Read More

YYForce (NASDAQ: YFOR) Wins Major UAE Hospitality Contracts as Middle East Expansion Accelerates

Secures Key Luxury Hospitality Deployments to Build Long-Term Regional Growth SINGAPORE and DUBAI, United Arab Emirates, Nov. 13, 2026 (GLOBE NEWSWIRE) — YYForce Inc. (NASDAQ: YFOR) (“YYForce” or the “Company”), an AI-enabled frontline workforce, robotics, and facility solutions provider today announced a major operational expansion across the Middle East market, highlighted by new client acquisitions […]

Read More